Characteristics of 4 patients who obtained 50% or greater reduction of FLC, without improvement of NT-proBNP
. | . | FLC, mg/L . | . | . | NT-proBNP, ng/L . | . | Mean VWT, mm . | . | NYHA class . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient no. . | FLC type . | Pre-Tx . | Post-Tx . | CR . | Pre-Tx . | Post-Tx . | Pre-Tx . | Post-Tx . | Pre-Tx . | Post-Tx . | ||||
| 1 | κ | 228.0 | 99.1 | No | 1 058 | 1 233 | 14 | 14 | II | II | ||||
| 2 | λ | 90.1 | 8.5 | No | 18 050 | 23 006 | 20 | 19 | III | III | ||||
| 3 | λ | 173.0 | 63.8 | No | 2 706 | 4 046 | 18 | 20 | II | II | ||||
| 4 | λ | 112.0 | 52.8 | No | 1 882 | 3 655 | 16 | 16 | II | II | ||||
. | . | FLC, mg/L . | . | . | NT-proBNP, ng/L . | . | Mean VWT, mm . | . | NYHA class . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient no. . | FLC type . | Pre-Tx . | Post-Tx . | CR . | Pre-Tx . | Post-Tx . | Pre-Tx . | Post-Tx . | Pre-Tx . | Post-Tx . | ||||
| 1 | κ | 228.0 | 99.1 | No | 1 058 | 1 233 | 14 | 14 | II | II | ||||
| 2 | λ | 90.1 | 8.5 | No | 18 050 | 23 006 | 20 | 19 | III | III | ||||
| 3 | λ | 173.0 | 63.8 | No | 2 706 | 4 046 | 18 | 20 | II | II | ||||
| 4 | λ | 112.0 | 52.8 | No | 1 882 | 3 655 | 16 | 16 | II | II | ||||
Pre-Tx indicates before therapy; Post-Tx, after treatment; CR, complete remission at immunofixation; and VWT, ventricular-wall thickness.